Drug developer PharmaEngine Inc (智擎生技) said its French partner Nanobiotix SA has received European market approval for PEP503 (NBTXR3), enabling commercialization of the nanoparticle radio-enhancer in the EU for the treatment of locally advanced soft-tissue sarcoma.
PEP503 would be marketed in the 27 EU countries under the brand name Hensify, PharmaEngine said in a filing with the Taiwan Stock Exchange on Saturday.
PharmaEngine in August 2012 acquired the exclusive rights from Nanobiotix to develop and commercialize PEP503 in the Asia-Pacific region.
PharmaEngine might be able to license the treatment to other companies in the region in the near term, the Chinese-language Commercial Times reported yesterday, adding that royalty revenue from sales could start from US$200 million.
PEP503 is a nanoparticle formulation of crystalline hafnium oxide that was designed to enhance the efficacy of radiotherapy for cancer treatment, the company said.
In addition to the treatment of soft-tissue sarcoma, PEP503 is being evaluated for other cancer types, such as head-and-neck cancer, liver cancer, rectal cancer and prostate cancer, PharmaEngine said.
In the US, the treatment has gained approval for a clinical trial in combination with anti-PD-1 immunotherapies for patients of non-small-cell lung cancer and head-and-neck cancer, the company said.
PharmaEngine reported cumulative revenue of NT$61.04 million (US$1.98 million) for the first two months of the year, up 96.29 percent from NT$31.1 million the previous year, a company regulatory filing showed.
The surge in revenue was mainly due to contributions from its pancreatic cancer drug, Onivyde, which has received reimbursements of NT$26,400 per vial from the National Health Insurance Administration since August last year.
The company posted net profit of NT$129.36 million for last year, or NT$0.88 in earnings per share, compared with the year-earlier level of NT$387.06 million, or NT$2.62 per share.
RECORD BUDGET: TSMC does plan to raise its proposed capital expenditure a lot, and could benefit if Intel outsources more of its production to foundries, analysts said Intel Corp’s earnings conference call on Thursday is expected to clarify the US semiconductor giant’s outsourcing production plans, which would be crucial regarding Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) performance, analysts said. “TSMC stands to benefit if Intel outsources more of its fabrication to foundries,” SinoPac Securities Investment Service Corp (永豐投顧) analysts said in a note on Friday. Yuanta Securities Investment Consulting Co (元大投顧) was more cautious, saying that Intel’s contribution initially would be limited, but its outsourcing plans would still highlight TSMC’s leadership in technology, it added. “Intel will continue to manufacture server or high-end central processing units [CPUs], which have higher
MediaTek Inc (聯發科) yesterday announced it would give incentive bonuses totaling NT$1.7 billion (US$59.7 million) to its employees and those at the firm’s major subsidiaries, after the smartphone chip supplier’s revenue hit US$10 billion last year. This is the biggest incentive bonus the Hsinchu-based handset chip designer has ever distributed in its 23-year history. About 17,000 full-time employees of MediaTek and five of its subsidiaries, including Richtek Technology Corp (立錡科技) and Airoha Technology Corp (絡達科技), would receive a “red envelope” of NT$100,000 each, the company said. “Surpassing US$10 billion is just the beginning. We will continue to [grow] on this basis,” MediaTek
TO SPUR REVENUE: The contract chipmaker expects its profit to grow 15 percent this year, outpacing the foundry industry’s projected advance of about 10 percent Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday raised its projected capital spending for this year by 62 percent, a new high, in an attempt to satisfy customer demand for advanced technologies in the production of central processing units, high-performance-computing (HPC) devices and 5G applications. After investing US$17.24 billion last year, TSMC this year plans to spend US$25 billion to US$28 billion on manufacturing equipment and new facilities, including a fab in the US. About 80 percent of the budget would be allocated for developing advanced technologies including 3, 5 and 7-nanometer technologies, the company said. The larger-than-expected capital spending prompted speculation
Norway’s oil and gas reserves have made it one of the world’s wealthiest countries, but its dreams for deep-sea discovery now center on something different. This time, Oslo is looking for a leading role in mining copper, zinc and other metals found on the seabed and in hot demand in green technologies. The country could license companies for deep-sea mining as early as 2023, the Norwegian Ministry of Petroleum and Energy said, potentially placing it among the first countries to harvest seabed metals for electric vehicle batteries, wind turbines and solar farms. However, that could also place it on the front line of